Active prevention of postpartum endometritis in pregnant women with anaerobic dysbiosis and planned cesarian section.
DOI:
https://doi.org/10.26641/2307-0404.2015.3.53126Keywords:
vaginal dysbiosis, diagnosis, pharmacological therapy, prevention of postpartum purulent-septic infection, planned caesarean sectionAbstract
In the structure of inflammatory diseases postpartum endometritis (PE) retains its leading position. The likelihood of postpartum endometritis development after cesarean section increases by 5-10 times compared with spontaneous labor and its frequency has no tendency to decrease. The urgency of PE problem is determined not only by its high prevalence, economic losses, but its possible complications (uterine suture failure and generalization of infection as well). Clinical picture of PE currently is characterized by late manifastation, presence of atypical and asymptomatic forms with mismatched general reaction of the organism and severity of the local pathological process. The leading role in the etiology of PE belongs to conditionaly pathogenic microflora, in the most cases (90%) presence of strict anaerobic nonsporeforming microorganisms, composing part of the normal flora of the genital tract in women. The aim of the study was the development of the principles of active prevention of postpartum endometritis in women with severe vaginal anaerobic dysbiosis while planning cesarean section.
References
Boldyreva MN. ["Femoflor" study biocenosis uro¬genital tract of women in reproductive age using PCR with the detection result in real time]. Toolkit for doctors. 2010;12. Russian. 2. Kupert MA, Solodun PV, Kupert AF. [Endo¬met¬ritis after childbirth (line group, Features and clinical diagnosis)]. Ross. Journal obstetrics-gynekology. 2003;4:42-46. Russian. 3. Mozheyko LF, Verbitskaya MS. [Sonographic examination of the uterus and uterine blood flow parameters in the diagnosis of postpartum endometritis. Med. panorama]. 2011;6:8-12. Russian. 4. Tirskaya YI, Dolgikh TI, Lazareva LI. [Features of pathogenic organisms in parturients high infectious risk]. Meditsina i obrazovanie v Sibiri. 2013;1:1-16. Russian. 5. Plakhova KI. [Features bacterial vaginosis the¬rapy, associate with Atopobium vaginale, and is charac¬terized by secretions with vagina s Using DNA] Chip: Avtoreferat 14.01.01. «Obstetrics and hynekolohyya». 2007;20. Russian. 6. Cape А, Tuomala RE, Taylor С. [Peripartum bac¬teremia in the era of group B streptococcus prophylaxis]. Obstet Gynecol. 2013; 121(4):812-8. Russian. 7. Polatti F. Bacterial vaginosis, atopobium vaginae and nifuratel. Current Clinical Pharmacology. 2012;7(1):36-40. 8. Hillier SL, Cosentino L, Petrina M. Susceptiblity of bacterial vaginosis (BV)-associated bacteria and lactobacilli to rifaximin, metronidazole and clindamycin. Sex. Transm. Infect. 2013;89:28-29.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Medical Perspectives
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
